The impairment of sympathetic innervation of the urinary bladder neck was supposed to be a cause of the syndrome of diabetic retrograde ejaculation (DRE). The performance of the sphincter system had not been studied in this category of patients. The liquid profilometric technique was used to examine 3 groups of males: 8 patients with the DRE syndrome; 5 patients with diabetes mellitus (DM) without ejaculation disorders; and 7 apparently healthy subjects. All the examinees showed no organic changes in the prostate and urethra. The groups were matched by age, type, duration and severity of DM. The DRE syndrome patients had no elevation of intraureteral pressure in the area the inner sphincter of the urinary bladder, which evidenced its atony. In health the elevation of vesical pressure is usually accompanied by an increase in ureteral resistance (r = 0.96; p less than 0.001), thus maintaining the stability of the positive pressure gradient and preventing the escape of urine. Correlation analysis revealed alterations of interrelations between intravesical and sphincter pressures in diabetes mellitus patients. This phenomenon evidenced the disorders of somatic innervation of the outer ureteral sphincter more pronounced in patients with the DRE syndrome. No significant differences were revealed in the length of the anatomical and functional ureter as well as in the length of the posterior ureter of all the patients involved in the study.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

dre syndrome
12
retrograde ejaculation
8
urinary bladder
8
patients dre
8
syndrome patients
8
diabetes mellitus
8
patients
7
[the function
4
function closure
4
closure apparatus
4

Similar Publications

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). Here, we present a case of a patient with Lennox-Gastaut Syndrome (LGS) treated with fenfluramine with development of PAH and tricuspid regurgitation that resolved upon discontinuation.

View Article and Find Full Text PDF

The efficacy of vagus nerve stimulation for epilepsy in Malaysia.

Med J Malaysia

November 2024

Universiti Malaya, Faculty of Medicine, Department of Medicine, Division of Neurology, Kuala Lumpur, Malaysia.

Introduction: The first vagus nerve stimulation (VNS) implantation in Malaysia was back in 2000, and the implantation rate increased tremendously since 2019. VNS has been used in patients who had persistent seizures despite epilepsy surgeries or were not candidates for epilepsy surgeries. We aimed to study the efficacy of VNS in Malaysia.

View Article and Find Full Text PDF
Article Synopsis
  • - CBD is emerging as a beneficial treatment for children with drug-resistant epilepsy (DRE), particularly for conditions like Dravet syndrome, Lennox Gastaut syndrome, and Tuberous sclerosis complex, with regulatory approval in multiple countries.
  • - Clinical trials indicate that CBD can reduce seizure frequency and improve the quality of life for affected children, with a generally favorable safety profile, though minor side effects like sleepiness and diarrhea may occur.
  • - Accessibility and cost remain significant issues, especially in lower-income regions such as India, prompting a discussion on the opportunities and hurdles of integrating CBD into clinical practice while navigating the evolving regulatory environment.
View Article and Find Full Text PDF

Introduction: Drug-resistant epilepsy has a cumulative incidence between 14 and 20% of patients with epilepsy. It is associated with more comorbidities and with higher healthcare expenditure and impact on quality of life.

Patients And Methods: A retrospective longitudinal descriptive study was performed covering the period from 01/01/2010 to 02/28/2024.

View Article and Find Full Text PDF
Article Synopsis
  • Sodium valproate is commonly used to treat seizures, chronic pain, and bipolar disorder, but it can cause severe side effects like valproate-induced hyperammonemic encephalopathy (VHE), which is life-threatening.
  • A study reviewed four neurosurgical patients who developed VHE after using valproate for seizure prevention, revealing a 50% mortality rate and indicating that prompt diagnosis and treatment are crucial.
  • Treatment involved discontinuing valproate and, in some cases, dialysis; half of the patients experienced clinical improvement after normalization of ammonia levels.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!